Guideline Summary – Oral Morphine → Tramadol Conversion Is Not Recommended

1. Potency and Analgesic Efficacy

Tramadol is roughly one‑tenth as potent as morphine, so a dose of 48 mg oral morphine would theoretically require about 480 mg tramadol per day to achieve comparable analgesia. (NCCN guideline, moderate‑quality evidence) 1
Tramadol provides inferior analgesia to morphine for cancer‑related pain; a Cochrane systematic review concluded that tramadol’s pain relief is significantly lower than that of morphine. (Cochrane review, high‑quality evidence) 1

Maximum recommended daily dose – 400 mg for immediate‑release (IR) formulations and 300 mg for extended‑release (ER) formulations – is set to minimise seizure risk. (NCCN guideline, strong recommendation) 1
Elderly patients (≥75 years) and those with hepatic or renal impairment require lower tramadol doses because of reduced clearance and heightened toxicity risk. (NCCN guideline, moderate‑quality evidence) 1
Serotonin‑syndrome risk when tramadol is combined with serotonergic agents (SSRIs, SNRIs, tricyclic antidepressants, MAOIs). (NCCN guideline, strong recommendation) 1
CYP2D6 genetic polymorphism leads to marked inter‑individual variability in tramadol metabolism, influencing both efficacy and adverse‑event profile. (NCCN guideline, expert consensus) 1

In cancer patients, tramadol is associated with higher rates of vomiting, dizziness, and generalized weakness compared with other opioids. (NCCN guideline, moderate‑quality evidence) 1
An observational study found comparable analgesic efficacy between high‑dose tramadol (≥300 mg/day) and low‑dose morphine (≤60 mg/day), but patients on morphine experienced more constipation, neuro‑psychological symptoms, and pruritus. (NCCN guideline, low‑quality evidence) 1

Initial dosing: start with 50–100 mg tramadol every 4–6 hours (IR). (NCCN guideline, moderate‑quality evidence) 1
Do not exceed 400 mg/day total for IR or 300 mg/day for ER formulations. (NCCN guideline, strong recommendation) 1
Monitoring: closely assess pain control; if analgesia is inadequate, promptly consider switching to an alternative opioid. (Annals of Oncology, expert opinion) 7

Continue morphine if the patient tolerates it. (Annals of Oncology, expert opinion) 8
Rotate to another strong opioid (e.g., oxycodone, hydromorphone) using established equianalgesic ratios. (Annals of Oncology & Journal of Clinical Oncology, moderate‑quality evidence) [7][9]10
Consult pain‑management or palliative‑care specialists for complex opioid conversions. (Journal of Clinical Oncology, expert consensus) 10

Tramadol is a weak opioid intended for moderate‑to‑moderately severe pain and should not be used as a substitute for strong opioids such as morphine when treating moderate‑to‑severe cancer pain. (NCCN guideline, strong recommendation) 1